ICD-10-CM Billable Code

T38.5X2

Poisoning by other estrogens and progestogens, intentional self-harm

Clinical Classification Guidelines

Medical Intelligence & Overview

Poisoning by other estrogens and progestogens, classified under ICD-10 code T38.5X2, involves the intentional ingestion or exposure to hormone-related substances for self-harm purposes. Estrogens and progestogens are types of hormones often used in hormone therapy, contraceptives, or other medical treatments. However, in cases of poisoning, these substances are taken in excessive or toxic amounts, which can have serious health effects. This article aims to provide a comprehensive, patient-friendly overview of this condition, including causes, symptoms, diagnosis, and treatment options.

Causes & Symptoms

Clinical Causes: Intentionally ingesting large quantities of estrogen or progestogen medications as an act of self-harm Misuse of hormonal therapies without medical supervision Attempting to induce specific physical or emotional effects through hormone overdose Psychological conditions such as depression or suicidal ideation leading to deliberate poisoning Accidental overdose in individuals with access to these hormones

Key Symptoms: Nausea and vomiting Abdominal pain or cramping Breast tenderness or swelling Unusual menstrual bleeding or changes Headaches and dizziness Mood swings or emotional disturbances Breast discharge or swelling Signs of hormonal imbalance such as hot flashes or sweating In severe cases, cardiovascular issues, blood clots, or liver problems In cases of overdose, potential for respiratory depression or altered consciousness

Diagnostic & Treatment

Diagnosis Path: Diagnosing poisoning by estrogens and progestogens involves a combination of medical history review, physical examination, and laboratory testing. Healthcare providers may request blood tests to measure hormone levels, liver function tests, and other relevant investigations to assess the extent of toxicity. A mental health evaluation is also essential to understand the context of self-harm and to provide appropriate psychological support. The diagnosis aims to confirm the overdose, rule out other causes, and develop an effective treatment plan.

Treatment Protocols: Treatment for poisoning by estrogens and progestogens typically includes supportive care and monitoring. In some cases, medical interventions may involve: - Activated charcoal to prevent further absorption of the hormones - Intravenous fluids to maintain hydration and support organ function - Medications to manage symptoms such as nausea, pain, or hormonal imbalances - Monitoring for complications like blood clots or liver issues - Psychiatric evaluation and counseling to address underlying mental health concerns and prevent recurrence Patients may require admission to a healthcare facility for close observation, especially in severe cases or if complications arise. Long-term management may involve therapy and support services to address psychological factors that contributed to the self-harm behavior.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T38.5X2 a billable ICD-10 code?
Yes, T38.5X2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T38.5X2?
Clinical documentation must specify the nature of Poisoning by other estrogens and progestogens, intentional self-harm and any associated comorbidities for accurate reporting.

Cite this Clinical Reference